1 study found for:    22735384 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma
Condition: Cancer
Interventions: Drug: GSK2118436;   Drug: Dacarbazine (DTIC)

Indicates status has not been verified in more than two years